FindTrial
Sign In

A clinical trial to study the effects of two Ayurveda Drugs,Bharangyadi Taila Nasya and Anu Taila Nasya in Patients of Pratishyaya with special reference to Allergic Rhinitis.

Randomised Comparative Clinical Study to Evaluate the Effect of Bharangyadi Taila Nasya and Anu Taila Nasya in the Management of Pratishyaya with special reference to Allergic Rhinitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029665
Enrollment
330
Registered
2020-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Bharangyadi Taila: DOSE: 6 Drops in Each Nostril Only Once in the Morning. ROUTE:Nasal Route DURATION :21 Days. REF: Charak Samhita.Chikitsa. Chapter :26/153 Control Intervention1:

Sponsors

Gangaprasad A Waghmare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who fulfill diagnostic criteria of Pratishyay (Allergic Rhinitis). 2. Patients suffering from Vataj, Pittaj , Kaphaj & Sannipataj Pratishyaya. 3. Patients having allergic history 4. Rhinoscopic Examination Suggesting Allergic Rhinitis.

Exclusion criteria

Exclusion criteria: 1. Pregnant & lactating mothers. 2. Patient who are not willing to participate. 3. Patient suffering from nasal polyp, epistaxis, Benign & Malignant tumors. 4. Patient having major nasal Structural Deformity. 5. Patient having Immunosuppression.

Design outcomes

Primary

MeasureTime frame
ANTIALLERGIC EFFECT OF NASYATimepoint: 21 DAYS—

Secondary

MeasureTime frame
ANTIALLERGIC EFFECT OF NASYATimepoint: 15 DAYS—

Countries

India

Contacts

Public ContactGANGAPRASAD A WAGHMARE

Tilak Maharashtra Vidyapeeth,Pune

pasuru@gmail.com9822885952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026